NCT00491530
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
See it on ClinicalTrials.gov ↗310 people
47.7%
52.3%
148 womenmiddle line = equal numbers162 men
- Phase
- PHASE3
- Paid for by
- Abbott
- Finished
- 2008-11
- Health conditions
- Mixed Dyslipidemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 55.8 years
- Age 65+
- 20.6%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.